PCNA and sarcoma: Immunostaining for CD3 and PCNA was performed at weeks 16, 20–24 and 30 using lymph node tissue (Figure S1) and human undifferentiated sarcoma tissue with high mitotic activity (Figure S2) as respective positive controls.